TP53 and gastric cancer: According to the differential expressions of a series of gene signatures, such as EMT, MSI, cytokine signaling, cell proliferation, DNA methylation, TP53 activity, and gastric tissue, GC could be classified into four molecular subtypes with distinct molecular characteristics and different clinical outcomes.